Profile data is unavailable for this security.
About the company
Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
- Revenue in SEK (TTM)210.12m
- Net income in SEK8.33m
- Incorporated2016
- Employees91.00
- LocationPaxman AB (publ)Pirgatan 13KARLSHAMN 374 35SwedenSWE
- Websitehttps://www.paxman.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boule Diagnostics AB | 576.03m | 26.98m | 388.33m | 233.00 | 14.56 | 0.7798 | 7.06 | 0.6742 | 0.6868 | 0.6868 | 14.79 | 12.82 | 0.7378 | 4.35 | 3.53 | 2,526,443.00 | 3.44 | 1.67 | 4.73 | 2.40 | 43.73 | 43.50 | 4.67 | 2.04 | 1.05 | 4.77 | 0.2638 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Karolinska Development AB | 1.94m | 33.61m | 421.62m | 8.00 | 12.65 | 0.341 | 12.23 | 217.66 | 0.1245 | 0.1245 | 0.0072 | 4.62 | 0.0016 | -- | 1.66 | 242,125.00 | 2.71 | 3.37 | 2.73 | 3.83 | -- | -- | 1,734.95 | 1,466.36 | -- | -- | 0.0023 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
| Modulight Oyj | -1.16tn | -1.16tn | 534.86m | 70.00 | -- | 0.8548 | -- | -- | -- | -- | -- | 1.26 | -- | -- | -- | -- | -- | -8.39 | -- | -9.10 | -- | 114.69 | -- | -56.81 | 6.11 | -- | 0.1004 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| BrainCool AB (publ) | 29.15m | -57.05m | 582.80m | 22.00 | -- | 4.80 | -- | 20.00 | -0.2848 | -0.2848 | 0.1465 | 0.4792 | 0.2418 | 2.09 | 3.32 | 1,214,417.00 | -47.34 | -47.14 | -56.18 | -70.16 | -50.61 | -149.77 | -195.75 | -391.45 | 0.7253 | -7.34 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| Bioretec Oy | 45.40m | -44.03m | 626.28m | 37.00 | -- | 6.29 | -- | 13.79 | -0.1984 | -0.1984 | 0.2047 | 0.4213 | 0.5524 | 1.46 | 3.68 | 105,594.60 | -53.58 | -67.11 | -65.75 | -97.60 | 69.85 | 70.97 | -96.98 | -134.05 | 4.86 | -4.02 | 0.0754 | -- | 32.77 | 19.77 | -56.82 | -- | -- | -- |
| Senzime AB (publ) | 40.59m | -131.28m | 663.74m | 52.00 | -- | 2.24 | -- | 16.35 | -1.30 | -1.30 | 0.3902 | 2.95 | 0.1045 | 1.34 | 5.80 | -- | -33.80 | -35.69 | -35.58 | -38.00 | 26.75 | -20.59 | -323.45 | -558.68 | 5.85 | -- | 0.0308 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Paxman AB (publ) | 210.12m | 8.33m | 758.60m | 91.00 | 91.56 | 6.19 | 28.16 | 3.61 | 0.4358 | 0.4358 | 11.03 | 6.45 | 1.23 | 2.70 | 7.67 | 2,308,978.00 | 4.89 | -5.08 | 6.65 | -7.76 | 69.68 | 69.38 | 3.96 | -5.07 | 1.67 | 2.71 | 0.1251 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Mentice AB | 254.07m | -25.98m | 802.86m | 128.00 | -- | 5.92 | 1,958.20 | 3.16 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| OssDsign AB | 117.72m | -118.39m | 864.28m | -- | -- | 3.85 | -- | 7.34 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | -- | -39.29 | -38.80 | -43.39 | -44.72 | 77.15 | 72.29 | -100.57 | -203.05 | 5.18 | -36.90 | 0.013 | -- | 96.82 | 53.26 | -31.30 | -- | -60.35 | -- |
| Integrum AB | 96.19m | 8.26m | 950.27m | 34.00 | 119.46 | 6.68 | 91.65 | 9.88 | 0.447 | 0.447 | 5.19 | 7.99 | 0.5918 | 0.5859 | 3.83 | -- | 5.08 | -6.65 | 5.65 | -7.95 | 86.80 | 81.52 | 8.58 | -11.19 | 3.04 | -4.28 | 0.0462 | -- | 33.29 | 37.39 | -117.50 | -- | 86.42 | -- |
Data as of May 23 2024. Currency figures normalised to Paxman AB (publ)'s reporting currency: Swedish Krona SEK
14.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Bank of New York Mellon Corp. (Investment Management)as of 31 Dec 2022 | 995.58k | 5.24% |
| Alcur Fonder ABas of 31 Dec 2022 | 806.33k | 4.24% |
| L�nsf�rs�kringar Fondf�rvaltning ABas of 31 Dec 2022 | 585.00k | 3.08% |
| Andra AP-fondenas of 31 Dec 2022 | 456.62k | 2.40% |
More ▼
Data from 15 Feb 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
